Irb - Nybc

HIV/AIDS Risk Reduction Interventions for African-American
Heterosexual Men

0920-09XX

Attachment 8b
Local IRB Approval – NYBC

NewYork Blood Center
INSTITUTIONAL REVIEW BOARD (IRB)

3 10 E. 67th Street, New YOI'll, NY 10065

2 12/5 70-3000

FClX

Phone. 212-5 70-3038 , Fax: 212-570-3343
E-Mail: nmoynihan @nybloodcenler.org

2 12/570 -3 195

MEMORANDUM

TO:

Beryl Koblin, Ph.D .

FROM :

Beau Mitchell, M .D.
IRB Co-Chair

DATE:

March 16,2010

RE :
IRB# 614-1 0

New Study Final Approval

VOTING DEFERRED FROM PREVIOUS MEETING:_2/16/10
IRB# 614-10: Review of Dr. Koblin's responses to Board issues and questions from the
February 16,2010 meeting. The Board had voted to defer final review to March 16,2010
if responses were received prior to this meeting. PI's responses received on March 12,
2010 and were sent electronically to the Board the same day . Modified March Agenda
resent to Board members electronically to reflect this additional Agenda item .
The Board vot ed unanimously to accept the responses. Fifteen votes for, no abstentions.

IRB approval for this protocol expires on 3/15111. It is your responsibility to ensure that
a complete application for continuing review and approval (renewal) is submitted by the
required time: 15 days before the IRB monthly meeting prior to your expiration date.

********
PLEASE NOTE: Federal regulations require that any serious untoward reactions must
be reported to the Board immediately. These regulations also require that any changes
in the protocol and/or the consent form must be approved by the Institutional Review
Board before use. The termination ofa protocol is also cons idered a chang e which must
be reported to the IRE.